Advertisement

Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation

  • Ryota Hamada
  • Tadakazu KondoEmail author
  • Masanobu Murao
  • Jyunsuke Miyasaka
  • Michiko Yoshida
  • Manabu Nankaku
  • Junya Kanda
  • Akifumi Takaori-Kondo
  • Ryosuke Ikeguchi
  • Shuichi Matsuda
Original Article
  • 54 Downloads

Abstract

Purpose

The purpose of this study was to retrospectively investigate the effect of the severity of acute graft-versus-host disease (GVHD) on physical function after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Methods

76 patients were included as subjects of this study. Severity of acute GVHD was classified according to the method defined by Grucksberg. To evaluate physical function, the knee extensor strength and six-minute walk distance (6MWD) were performed.

Results

Among these patients, 54% developed acute GVHD; of these, 32%, 54%, and 15% of patients had grade I, grade II, and grades III–IV GVHD, respectively. In the grade I–II groups, mild acute GVHD following allo-HSCT resulted in a gradual decline in physical function, which improved at discharge. However, in cases of severe acute GVHD, physical function deteriorated, implementation of rehabilitation became difficult, and the decline in physical function persisted even at discharge.

Conclusion

These results indicate that severe acute GVHD negatively affects physical function leading to longer hospital days because of inadequate rehabilitation interventions.

Keywords

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) Acute graft-versus-host disease (GVHD) Six-minute walk distance (6MWD) Knee extensor strength 

Notes

Acknowledgements

We are grateful to the medical, nursing, and laboratory staff of the participating departments for their contributions to this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Institutional Review Board of Kyoto University Hospital conducted in accordance with the international ethical recommendations stated in the Japanese Good Clinical Practice Guidelines.

References

  1. 1.
    The Japanese Data Center for Hematopoietic Cell Transplantation, The Japan Society for Hematopoietic Cell Transplantation (2016) Hematopoietic cell transplantation in Japan annual report of nationwide survey.  https://doi.org/10.11386/jst.52.2-3_184
  2. 2.
    Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high dose steroid therapy. Bone Marrow Transplant 38(4):299–303.  https://doi.org/10.1038/sj.bmt.1705435 CrossRefPubMedGoogle Scholar
  3. 3.
    Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM et al (1993) Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329(17):1225–1230.  https://doi.org/10.1056/NEJM199310213291703 CrossRefPubMedGoogle Scholar
  4. 4.
    Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE et al (1990) Appelbaum FR et al. A retrospective analysis of therapy for acute graft versus-host disease initial treatment. Blood 76(8):1464–1472CrossRefGoogle Scholar
  5. 5.
    Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S, Nakae J, Tagata Y, Nishitani S, Takehana K, Sano M, Fukuda K, Suematsu M, Morimoto C, Tanaka H (2011) Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13(2):170–182.  https://doi.org/10.1016/j.cmet.2011.01.001 CrossRefPubMedGoogle Scholar
  6. 6.
    Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, Antona GD (2011) Steroid myopathy: some unresolved issues. J. Endocrinol. Invest. 34:370–375CrossRefGoogle Scholar
  7. 7.
    Schäcke H, Döcke WD, Asadullah K (2002) Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96(1):23–43.  https://doi.org/10.1016/S0163-7258(02)00297-8 CrossRefPubMedGoogle Scholar
  8. 8.
    Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM (1997) Steroid myopathy in cancer patients. Neurology 48(5):1234–1238.  https://doi.org/10.1212/WNL.48.5.1234 CrossRefPubMedGoogle Scholar
  9. 9.
    Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP (2013) Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 45(10):2163–2172.  https://doi.org/10.1016/j.biocel.2013.05.036 CrossRefPubMedGoogle Scholar
  10. 10.
    Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295–304CrossRefGoogle Scholar
  11. 11.
    Nankaku M, Tsuboyama T, Kakinoki R, Akiyama H, Nakamura T (2011) Prediction of ambulation ability following total hip arthroplasty. J Orthop Sci 16(4):359–363.  https://doi.org/10.1007/s00776-011-0067-x CrossRefPubMedGoogle Scholar
  12. 12.
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117.  https://doi.org/10.1164/ajrccm.166.1.at1102 CrossRefGoogle Scholar
  13. 13.
    Borg GA (1982) Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise 14(5):377–381CrossRefGoogle Scholar
  14. 14.
    Hill DC, Ethans KD, MacLeod DA, Harrison ER, Matheson JE (2005) Exercise stress testing in subacute stroke patients using a combined upper- and lower-limb ergometer. Arch Phys Med Rehabil 86(9):1860–1866CrossRefGoogle Scholar
  15. 15.
    Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC (2008) Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 41(11):965–969.  https://doi.org/10.1038/bmt.2008.15 CrossRefPubMedGoogle Scholar
  16. 16.
    Ishikawa A, Okata Y, Kamisako M, Suzuki T, Miyata C, Tsuji T, Matsumoto H, Kato J, Mori T, Okamoto S, Liu M (2019) Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Support Care Cancer 27(5):1793–1800.  https://doi.org/10.1007/s00520-018-4433-5 CrossRefPubMedGoogle Scholar
  17. 17.
    Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation (2012) Diagnosis and management of acute graft-versus-host disease. Br J Haematol 158(1):30–45.  https://doi.org/10.1111/j.1365-2141.2012.09129.x CrossRefGoogle Scholar
  18. 18.
    Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A (1990) Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 75(4):1024–1030CrossRefGoogle Scholar
  19. 19.
    Ruutu T, Niederwieser D, Gratwohl A, Apperley JF (1997) A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 19(8):759–764.  https://doi.org/10.1038/sj.bmt.1700745 CrossRefPubMedGoogle Scholar
  20. 20.
    Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE (1990) A retrospective analysis of therapy for acute graft-versus host disease: initial treatment. Blood 76(8):1464–1472CrossRefGoogle Scholar
  21. 21.
    Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA (2012) First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biology of blood and marrow transplantation. Biol Blood Marrow Transplant 18(8):1150–1163.  https://doi.org/10.1016/j.bbmt.2012.04.005 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Mello M, Tanaka C, Dulley FL (2003) Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 32(7):723–728.  https://doi.org/10.1038/sj.bmt.1704227 CrossRefPubMedGoogle Scholar
  23. 23.
    Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA (2009) A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 45(2):355–362.  https://doi.org/10.1038/bmt.2009.163 CrossRefPubMedGoogle Scholar
  24. 24.
    Rovelli A, Pezzini C, Silvestri D, Tana F, Galli MA, Uderzo C (1995) Cardiac and respiratory function after bone marrow transplantation in children with leukaemia. Bone Marrow Transplant 16(4):571–576PubMedGoogle Scholar
  25. 25.
    Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87(2):148–156.  https://doi.org/10.1111/j.1600-0609.2011.01640.x CrossRefPubMedGoogle Scholar
  26. 26.
    Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology 22(5):1159–1166.  https://doi.org/10.1002/pon.3128 CrossRefPubMedGoogle Scholar
  27. 27.
    Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43(9):725–737.  https://doi.org/10.1038/bmt.2009.27 CrossRefPubMedGoogle Scholar
  28. 28.
    Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A, Schissel K, McGlave PB, Ramsay NK, Kersey JH (1987) Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43(6):833–838CrossRefGoogle Scholar
  29. 29.
    Berg HE, Larsson L, Tesch PA (1997) Lower limb skeletal muscle function after 6wk of bed rest. J Appl Physiol 82(1):182–188.  https://doi.org/10.1152/jappl.1997.82.1.182 CrossRefPubMedGoogle Scholar
  30. 30.
    Khaleeli AA, Edwards RH, Gohil K, McPhail G, Rennie MJ, Round J, Ross EJ (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 18(2):155–166CrossRefGoogle Scholar
  31. 31.
    Johnson MA, Polgar J, Weightman D, Appleton D (1973) Data on the distribution of fiber types in thirty-six human muscles. J Neurol Sci 18(1):111–129.  https://doi.org/10.1016/0022-510X(73)90023-3 CrossRefPubMedGoogle Scholar
  32. 32.
    Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K (2017) Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. Eur J Cancer Care (Engl) 26(4).  https://doi.org/10.1111/ecc.12669 CrossRefGoogle Scholar
  33. 33.
    Takekiyo T, Dozono K, Nara S, Murayama Y, Minamihama N, Nakano N, Kubota A, Tokunaga M, Miyazono T, Takeuchi S, Takatsuka Y, Utsunomiya A (2017) Gender differences in physical function and muscle mass change in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52(10):1460–1462.  https://doi.org/10.1038/bmt.2017.156 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Ryota Hamada
    • 1
  • Tadakazu Kondo
    • 2
    Email author
  • Masanobu Murao
    • 1
  • Jyunsuke Miyasaka
    • 1
  • Michiko Yoshida
    • 1
  • Manabu Nankaku
    • 1
  • Junya Kanda
    • 2
  • Akifumi Takaori-Kondo
    • 2
  • Ryosuke Ikeguchi
    • 1
  • Shuichi Matsuda
    • 1
  1. 1.Rehabilitation UnitKyoto University HospitalKyotoJapan
  2. 2.Department of Hematology and Oncology, Graduate School of MedicineKyoto UniversityKyotoJapan

Personalised recommendations